Archives: Research Summaries

NMOSD and MOGAD in Latin America: A consensus-informed regional perspective

NMOSD and MOGAD in Latin America: A consensus-informed regional perspective

Journal: Multiple Sclerosis and Related Disorders; October 1, 2026

Author(s): Vinícius Boldrinia, Sara Samadzadeh, Edgar Carnero Contentti, Vitória Pimentel, Natalia Szejko, Ethel Ciampil, Jacqueline Palace, Friedemann Paul, Jefferson Becker, Alfredo Damasceno, ECF Young Investigators/Fellows Initiative

NMOSD and MOGAD in Latin America: diagnosis, treatment, and associated challenges

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders

Journal: Neurology, Neuroimmunology & Neuroinflammation; April 27, 2026

Author(s): Qiao Xu, Linming Zhang, Xinyi Duan, Kai Zhou, Zhizhong Li, Xiaolin Yang, Jing Wang, Jinyu Jiang, Ke Xu, Gang Yu, Peng Zheng, Yongmei Li, Xinyue Qin, Jingyuan Li, Wen Ya Wang, He Zhao, Dehui Huang, Hao Qu, Haibing Xiao, Bin Li, Lei Wu, Jinzhou Feng

How effective is inebilizumab compared to low-dose rituximab for NMOSD?

Identification of genetic risk loci associated with aquaporin 4-positive NMOSD: a genome-wide association study

Identification of genetic risk loci associated with aquaporin 4-positive NMOSD: a genome-wide association study

Journal: The Lancet Neurology; May 1, 2026

Author(s): Kathrine E Attfield, Angelos P Armen, Subita Balaram Kuttikkatte, Redwan Farooq, Anna G Francis, Calliope A Dendrou, M Isabel Leite, Patrick Waters; International NMOSD Genetics Consortium; Brian G Weinshenker, Konrad J Karczewski, Benjamin M Neale, Lise Torp Jensen, Jamie Rossjohn, Ralf Gold, Thomas Korn, Gil McVean, Jacqueline Palace, Lars Fugger

Why do people develop NMOSD? A large-scale study to understand possible genetic factors

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD

Journal: Neurology Neuroimmunology & Neuroinflammation; January 7, 2026

Author(s): Thivya Pakeerathan , James Davis, Amanda D Henderson, Elias S Sotirchos, Yana Said, Joachim Havla, Marius Ringelstein, Orhan Aktas, Margit Weise, Jonathan A Gernert, Barbara Kornek, Gabriel Bsteh, Paulus S Rommer, Nik Krajnc, Anne-Katrin Pröbstel, Athina Papadopoulou, Laila Kulsvehagen, Roxanne Pretzsch, Kean Schoenholzer, Tanyatuth Padungkiatsagul, Heather E Moss, Sylvia E Villarreal Navarro, Marina Herwerth, Madalina Graure, Veronika Kana, Hadas Stiebel-Kalish, Rita Zlatkin, Anthony C Arnold, Laura Bonelli, Jan-Patrick Stellmann, Natacha Stolowy, Carolin Schwake, Christiane Schneider-Gold, Tania Kümpfel, Philipp Albrecht, Natthapon Rattanathamsakul, Sean J Pittock, Eoin P Flanagan, Sara Carta, Sara Mariotto, Ralf Gold, John J Chen, Ilya Ayzenberg

Could an eye test be used to distinguish between NMOSD and MOGAD in the first instance of optic nerve inflammation?

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results

TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results

Journal: Neurology, Neuroimmunology & Neuroinflammation; April 1, 2026

Author(s): Andreu Vilaseca, Angeliki G Filippatou, Yana Said, Elia Sechi, Stephanie B Syc-Mazurek, Laura Cacciaguerra, Kai Guo, Nisa Vorasoot, Moritz Niederschweiberer, Smathorn Thakolwiboon, Jessica A Sagen, Sebastian A Lopez-Chiriboga, Jan-Mendelt Tillema, John J Chen, Sean J Pittock, Elias S Sotirchos, Eoin P Flanagan

A new scoring system for more accurate MOGAD diagnosis in patients with anti-MOG antibodies

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study

Journal: Neurology; July 2, 2026

Author(s): Daniel Engels, Patrick Schindler, Joachim Havla, Katinka Fischer, Marius Ringelstein, Martin W Hümmert, Franziska Bütow, Insa Schiffmann, Charlotte Schubert, Judith Bellmann-Strobl, Katrin Giglhuber, Clarissa Zappe, Sven Jarius, Lisa Revie , Carolin Schwake, Ioannis Vardakas, Florian Then Bergh, Yavor Yalachkov, Annette Walter, Leila Husseini, Markus C Kowarik, Matthias Grothe, Antonios Bayas, Klemens Angstwurm, Steffen Pfeuffer, Uwe K Zettl, Ingo Kleiter, Clemens Warnke, Simone C Tauber, Jonathan Wickel, Makbule Senel, Ilya Ayzenberg, Luisa Klotz, Brigitte Wildemann, Achim Berthele, Vivien Häußler, Corinna Trebst, Orhan Aktas, Friedemann Paul, Tania Kümpfel ; as the Neuromyelitis Optica Study Group (NEMOS)

Understanding how disability may worsen or improve between relapses in patients with NMOSD and MOGAD

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD

Journal: The Lancet Neurology; March 1, 2026

Author(s): Dalia L Rotstein, Raed Alroughani, Georgina Arrambide, Edgar Carnero Contentti, Mashina Chomba, Kazuo Fujihara, Nils E Gilhus, Riadh Gouider, Jeannine M Heckmann, Ho Jin Kim, Hai-Feng Li, Maria Isabel Leite, Mastura Monif, Sasitorn Siritho, Sandra Thiel, Anastasia Vishnevetsky, Shanthi Viswanathan, Sandra Vukusic, Bassem Yamout, Tania Kümpfel, Kerstin Hellwig

Managing pregnancy and family planning in patients with myasthenia gravis, NMOSD, and MOGAD